The Institut national de la santé et de la recherche médicale ( Inserm , French pronunciation: [insɛʁm] ) is the French National Institute of Health and Medical Research.
4-984: Inserm was created in 1964 as a successor to the French National Institute of Health. Inserm is the only public research institution solely focused on human health and medical research in France. It is a public institution with a scientific and technical vocation under the dual auspices of the Ministry of Health and the Ministry of Research . Similarly to the US National Institutes of Health , Inserm conducts fundamental and translational research projects through 339 research units, run by around 13,000 scientists, including 5,100 permanent research staff members and 5,100 staff members co-affiliated with university hospitals and medicine faculties. Inserm's laboratories and research units are located all over France, mainly in
8-664: The 2019 Scimago Institutions Ranking , Inserm is the second-best research institution in the health sector (behind the NIH ) and twenty-second best across all sectors. Two Inserm research scientists have been awarded by the Nobel Prize in Physiology or Medicine . In 1980, the French immunologist Jean Dausset received the Nobel prize (along with Baruj Benacerraf and George Davis Snell ), for his work on
12-458: The discovery and characterisation of the genes making the major histocompatibility complex . In 2008, the French virologist Françoise Barré-Sinoussi was awarded, together with her former mentor Luc Montagnier , for the identification of the human immunodeficiency virus . Each year, Inserm awards three researchers in three major distinct categories. The Grand prix de l'Inserm recognizes major advancements in biology for an active researcher of
16-474: The largest cities. Eighty percent of Inserm research units are embedded in research hospitals of French universities. In 1997, Inserm founded Orphanet , a rare disease database. Inserm's CEO is chosen by decree upon a proposal of the Ministers of Health and Research, advised by a review committee. The CEO since January 2019 is Gilles Bloch, a doctor and researcher specializing in medical imaging. According to
#946053